UPDATE: BioCryst Pharma (BCRX) PT Raised to $21 at Cowen, Highlighted as Best Specialty Pharma SMidcap Idea of 2021
Tweet Send to a Friend
(Updated - June 17, 2021 6:39 AM EDT)
Cowen analyst Ken Cacciatore raised the price target on BioCryst Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cowen analyst Ken Cacciatore raised the price target on BioCryst Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
